Johnson & Johnson (JNJ) Stock Forecast & Price Prediction

Estimation of the future price movement of Johnson & Johnson stock, based on various factors such as historical price trends, market trends, company performance, and economic conditions.

Price target


Current $162.12

Concensus $175.50


Low $110.00

Median $177.50

High $205.00

Based on analysts projections #JNJ is expected to experience a positive growth trajectory over the next year.

The current average JNJ price target, as estimated by these analysts, is $175.50.

The predictions for the future JNJ stock price range from a low of $110.00 to a high of $205.00, highlighting the variability of market expectations for JNJ.

It is important to note that market fluctuations and unforeseen events can have an impact on these projections, so investors should always exercise caution and conduct thorough research before making any investment decisions.

JNJ stock forecasts by analyst

Analyst / firm Date Rating Price target Price when posted
Larry Biegelsen
Wells Fargo
December 28, 2023 Buy 163.00 156.35
Jayson Bedford
Raymond James
December 28, 2023 Sell 110.00 156.35
Shagun Singh
Johnson Rice
October 5, 2023 Buy 178.00 157.24
Trung Huynh
Johnson Rice
July 21, 2023 Buy 175.00 170.45
John Ransom
Raymond James
May 24, 2023 Sell 90.00 156.60
Citigroup December 12, 2022 Buy 205.00 176.17
Morgan Stanley December 6, 2022 Buy 176.00 178.79
Morgan Stanley December 1, 2022 Buy 178.00 178.49
UBS July 21, 2022 Buy 180.00 170.71
Larry Biegelsen
Wells Fargo
July 20, 2022 Buy 195.00 170.71
Steve Chesney
Atlantic Equities
July 20, 2022 Buy 165.00 170.71
Leerink Partners July 20, 2022 Buy 194.00 170.86
Raymond James July 20, 2022 Buy 192.00 171.69
Citigroup July 20, 2022 Buy 201.00 171.69
Morgan Stanley July 8, 2022 Buy 174.00 178.50
Citigroup April 20, 2022 Buy 210.00 183.51
Raymond James April 20, 2022 Buy 196.00 183.46
Credit Suisse April 20, 2022 Buy 205.00 182.64
Jayson Bedford
Raymond James
April 18, 2022 Buy 195.00 177.66
Matthew Harrison
Morgan Stanley
April 11, 2022 Buy 173.00 179.84
Florent Cespedes
Societe Generale
January 28, 2022 Buy 177.00 171.79
Chris Shibutani
Goldman Sachs
January 26, 2022 Buy 163.00 168.38
Matt Miksic
Credit Suisse
December 29, 2021 Buy 200.00 170.46
Kevin Caliendo
UBS
July 22, 2021 Buy 183.00 166.80
David Toung
Argus Research
July 22, 2021 Buy 190.00 166.80

Johnson & Johnson (JNJ) Fundamentals Checker

Financial metrics are used to evaluate financial stability which helps analysts determine if Johnson & Johnson is undervalued compared to its fair value. A company's financial health can strongly influence the stock forecast.

Strong Buy

Financial Scores

Updated on: 04/03/2024

Altman Z-Score: 4.7

Piotroski Score: 8.0

ESG Score

Updated on: 04/03/2024

Environmental: 82.8

Social: 68.7

Governance: 70.3

Financial Health

Updated on: 04/03/2024

DCF: Buy

ROE: Buy

ROA: Strong Buy

Debt to equity ratio: Buy

Price to earnings ratio: Strong Buy

Price to book ratio: Strong Buy

JNJ Discounted Cash Flow

Updated on: 04/03/2024

$167.538
Discounted Cash Flow Value


$162.120
Current Price

JNJ Revenues by Segment

Updated on: 04/03/2024

MedTech
$304,000,000.00

Revenue from Contract with Customer, Excluding Assessed Tax

JNJ Revenues by Region

Updated on: 04/03/2024

Asia-Pacific, Africa
$137,560,000.00
Europe
$204,100,000.00
UNITED STATES
$464,440,000.00
Western Hemisphere, excluding U.S.
$45,490,000.00

JNJ Notes Due

Updated on: 04/03/2024

CIKExchangeTitle

There are no data to display

Johnson & Johnson (JNJ) Social Sentiments

Monitoring bullish and bearish sentiments towards Johnson & Johnson on Twitter and Stocktwits could help to forecast an upward or downward trend in Johnson & Johnson stock price.

JNJ Stock Forecast: Strong Financials & Resilient Business Model Make Johnson & Johnson a Top Investment Opportunity

Johnson & Johnson (JNJ) is a well-known name in the pharmaceutical industry, operating in the Drug Manufacturers - General sector. This American multinational corporation is headquartered in New Jersey and produces a wide range of products that include medical devices, pharmaceuticals, and consumer health products. JNJ has consistently shown steady growth over the years, making it a great investment opportunity... Read more

JNJ Stock Prediction: A Promising Future for the Drug Manufacturers - General Sector

The Drug Manufacturers - General sector is one of the most prominent in the stock market, with a dedicated focus on producing and distributing drugs to consumers. Among the notable companies in this industry, Johnson & Johnson is among the leaders, boasting a significant market capitalization and a global presence. As of writing this article, Johnson & Johnson's stock ticker... Read more